Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 10:14 PM
Study NCT ID:
NCT01858558
Status:
COMPLETED
Last Update Posted:
2020-06-29
First Post:
2013-05-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-19
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-14
First Submit QC Date:
None
Study First Post Date:
2013-05-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-11
Results First Submit QC Date:
None
Results First Post Date:
2020-06-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-11
Last Update Post Date:
2020-06-29
Last Update Post Date Type:
ACTUAL